Guanze Medical Information Industry (Holding) Co., Ltd. on Wednesday, reported results for the year ended 2025.
The company posted a net loss of RMB 29.7 million for 2025, a significant drop from the net income of RMB 17.2 million they saw in 2024. This decline is mainly due to falling revenues and increasing impairment charges.
Earnings per share came in at a loss of RMB 0.03, down from earnings of RMB 0.02 the previous year. Overall revenue dropped to RMB 88.4 million, down from RMB 155.7 million in 2024, and gross profit fell to RMB 22.1 million from RMB 62.8 million.
Before tax, the loss was RMB31.4 million compared to a profit before tax of RMB26.3 million last year. Selling and distribution costs went up to RMB 20.0 million from RMB 17.8 million, while administrative expenses increased slightly to RMB14.2 million from RMB 13.8 million, and research and development expenses rose to RMB5.8 million from RMB 4.1 million.
Guanze Medical closed Wednesday's trading at HKD 3.540, down HKD 0.160 or 4.32 percent on the Hong Kong Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.